Circadian rhythm of serum phosphate, calcium and parathyroid hormone levels in hemodialysis patients

Clinical Laboratory

Volumn 59, Issue 1-2, 2013, Pages 79-84

  Micozkadioglu, H ^a   Ozelsancak, Ruya ^a   Yildiz, I ^a   Erken, E ^a   Zumrutdal, A ^a   Torun, D ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Calcium; Circadian rhythm; Hemodialysis; Parathyroid hormone; Phosphorus

Indexed keywords

ALBUMIN; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D DERIVATIVE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD VESSEL VOLUME; CALCIUM BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; MALE; MEDICAL HISTORY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL;

ADULT; AGED; CALCIUM; CIRCADIAN RHYTHM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS;

EID: 84874586256     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120205     Document Type: Article

References (15)

1. Esther A, Gonzales and Kevin J. Martin. Bone and Mineral Methabolism in Chronic Kidney Disease. In: J. Feehally, J. Floege, R.J. Johnson eds. Comprehensive Clinical Nephrology 3rd Ed. Philadelphia, Pa: Mosby Elsevier; 2007:869-881.
2. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol. 2003;14:S300-S304. (Pubitemid 37052394)
3. Ganesh SK, Stack AG, Levin NW, et al. Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131-2138. (Pubitemid 32880350)
4. Nakai S, Akiba T, Kazama J, et al. Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial. 2008;12:49-54. (Pubitemid 351197452)
5. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520-528. (Pubitemid 41725150)
6. Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif. 2010;29:137-144.
7. KDIGO guidelines. Chapter 4.2 Treatments of abnormal PTH levels in CKD-MBD, 2009.
8. th edition Philadelphia Pa: Lippincott Williams & Wilkins; 2007:583-606.
9. Jubiz W, Canterbury JM, Reiss E, et al. Circadian rhythm in serum parathyroid hormone concentration in human subjects correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest. 1972;51:2040-6.
10. Kemp GJ, Blumsohn A, Morris BW. Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts. Clin Chem. 1992;38:400-2.
11. Ring T, Sanden AK, Hansen HH, et al. Ultradian variation in serum phosphate concentration in patients on haemodialysis. Nephrol Dial Transplant. 1995;10:59-63.
12. Graziani G, Badalamenti S, Como G, et al. Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron. 2002; 91: 474-479. (Pubitemid 34765248)
13. Kemp GJ, Blumsohn A, Morris BW. Cellular phosphate shifts during oral glucose loading. Clin Chem. 1992;38:2338-2339.
14. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007;20:295-301.
15. el-Hajj Fuleihan G, Klerman EB, Brown EN, et al. The parathyroid hormone circadian rhythm is truly endogenous - a general clinical research center study. J Clin Endocrinol Metab. 1997;82:281-6. (Pubitemid 27021312)